http://archive.fast-edgar.com/20260914/ASV2G22MY222V2Z2222I22ZZSI2AT2Q22282
Filed on: September 14, 2026
http://archive.fast-edgar.com/20260914/ASBEV22D8222N2ZZ272T2MZZT8UKZ2S2Z282
Filed on: September 14, 2026
Harding, Loevner Funds, Inc.
Supplement dated September 14, 2026 to the
Summary Prospectuses (the “Summary Prospectuses”), each dated February 28, 2026, as supplemented, for:
Frontier Emerging Markets Portfolio (Investor Class, Institutional Class, and Institutional Class Z) and Institutional Emerging Markets Portfolio (Institutional and Institutional Class Z)
Prospectus for Institutional Investors, Prospectus for Individual Investors and Prospectus for... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 14, 2026
Perspective Therapeutics, Inc.
(Exact name of Registrant as Specified in Its Charter)
More SEC Filings
View Older Stories-
Form 497K HARDING LOEVNER FUNDS
-
Form 6-K VinFast Auto Ltd. For: Sep 14
-
Form 497 HARDING LOEVNER FUNDS
-
Form 424B2 Vistra Operations Co
-
Form 8-K Embrace Change Acquisiti For: Sep 10
-
Form 8-K Lipocine Inc. For: Sep 14
-
Form D/A Bin Yuan Greater China
-
Form D/A L&R ASIA CREDIT ALPHA
-
Form 6-K NOVONIX Ltd For: Sep 14
-
Form 6-K Radiopharm Theranostics For: Sep 14
-
Form 425 Translational Developmen Filed by: Prologium Holding Inc.
-
Form 6-K Zhihu Inc. For: Sep 14
-
Form 6-K Clearmind Medicine Inc. For: Sep 14
-
Form F-3 Radiopharm Theranostics
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 6-K Li Auto Inc. For: Sep 14
-
Form D/A Sage Partners Alpha 1
-
Form SCHEDULE 13G/A Grab Holdings Ltd Filed by: TOYOTA MOTOR CORP/
-
Form 3 Polar Power, Inc. For: Aug 17 Filed by: Ahern Jim
-
Form SCHEDULE 13G Safe Pro Group Inc. Filed by: FROST PHILLIP MD ET AL
-
Form 8-K WhiteFiber, Inc. For: Sep 14
-
Form 6-K PRUDENTIAL PLC For: Sep 14
-
Form S-1/A Electra Therapeutics,
-
Form 4 Alibaba Group Holding For: Sep 10 Filed by: Wu Yongming
-
Form 1-SA McQueen Labs Series, For: Jun 30
-
Form C/A Oravanti Ventures Inc
-
Form S-3ASR Tyra Biosciences, Inc.
-
Form DEF 14C SHARING ECONOMY INTERNAT For: Sep 14
-
Form 424B2 Jefferies Financial Grou
-
Form 6-K WOODSIDE ENERGY GROUP For: Sep 14
-
Form 15-12G Apogee Therapeutics,
-
Form 8-K Artificial Intelligence For: Sep 14
-
Form EFFECT ACCURAY INC
-
Form 6-K Biophytis SA For: Sep 11
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 6-K KE Holdings Inc. For: Sep 14
-
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 11 Filed by: Heshmatpour Amir F
-
Form EFFECT Eightco Holdings Inc.
-
Form EFFECT Wheeler Real Estate Inve
-
Form 6-K Nanobiotix S.A. For: Sep 14
-
Form EFFECT Strategic Storage Trust
-
Form EFFECT VS MEDIA Holdings Ltd
-
Form EFFECT Indivior Pharmaceuticals
-
Form 8-K ORACLE CORP For: Sep 12
-
Form 6-K NOMURA HOLDINGS INC For: Sep 14
-
Form EFFECT Nasus Pharma Ltd
-
Form EFFECT ENIGMATIG LTD

